Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.49545 | 20 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.46269 | 19 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.47967 | 20 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.42501 | 20 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.42029 | 19 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.52538 | 19 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.4856 | 19 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.45444 | 20 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.43559 | 19 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.46497 | 20 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.50155 | 22 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.44956 | 20 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.46958 | 20 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.46743 | 20 |